The unusual pairing of Oxford university scientists and British-Swedish pharmaceutical giant AstraZeneca led to the not for profit Covid-19 vaccine. Billions of doses have been produced but at cost for how long? And why did this particular vaccine receive such intense public scrutiny? We speak to Dr. Sanjeev Panchal, Country President of AstraZeneca Malaysia to find out.

Image credit: Shutterstock.com

Produced by: Shazana Mokhtar

Presented by: Wong Shou Ning

Download the BFM mobile app. Stay at home and stay up-to-date.

Tags:  Covid 19,  Pandemic,  Vaccinations,  Delta,  Malaysia,  Policy,  Healthcare,  AstraZeneca,  Vaccine Equity,  Government/Regulatory/Policy Making,  Healthcare, Pharma, Biotech,  Economy, Markets,  Politics, News, Current Affairs,  Health